Menu Close

Executive Interview Feature

Forging a company’s soul: Alessandro Maselli

From supporting the delivery of life-changing therapies to investing heavily in AI and next-gen drug manufacturing, Catalent is positioning itself at the center of biopharma’s future. President and CEO Alessandro Maselli shares why culture, partnerships and long-term thinking remain the company’s greatest competitive advantages.

Julie Cooper

Sponsored Content

Operational AI isn’t a tool, it’s how work gets done

Most organizations treat AI as a tool alongside the work, but the real shift happens when it becomes part of the work itself, quietly shaping decisions, workflows and outcomes before humans step in. Here’s how companies can ensure they get the operational foundations right and turn AI from experimentation into a true advantage.

Sync(d) AI

Executive Interview Feature

Kayla Itsines: Why buying back Sweat was even more rewarding than selling it

After building Sweat into a global fitness phenomenon and selling it in a deal reportedly worth hundreds of millions, Kayla Itsines discovered letting go was harder than she imagined. Now as sole owner once again, she’s leading the business into its next chapter – and redefining what success looks like along the way.

Julie Cooper

Executive Interview Feature

Engineering trust: Anthony Lau

After three decades working across Asia in semiconductor manufacturing, Anthony Lau has come to understand that while precision underpins day-to-day operations, trust is the true marker of great leadership.

Julie Cooper

Executive Interview Feature

Forging a company’s soul: Alessandro Maselli

Julie Cooper

Sponsored Content

Operational AI isn’t a tool, it’s how work gets done

Sync(d) AI

Executive Interview Feature

Kayla Itsines: Why buying back Sweat was even more rewarding than selling it

Julie Cooper

Executive Interview Feature

Engineering trust: Anthony Lau

Julie Cooper